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Abstract 
Antiretroviral drugs are used to prolong and improve the quality of life for those infected, but this therapy has 
associated side effects and adverse drug reactions (ADRs) of varying degrees in frequency and severity. A better 
understanding of adverse effects is of interest not only to the HIV specialists as they try to optimize on therapy 
but also to the patient who may not be aware of these adverse reactions due to the multiple symptoms associated 
with the AIDS syndrome. Not much is known about ADRs in Nigeria.  The objective of this study was to 
determine the incidence and management of various ADRs occurring in patients accessing treatment and care at 
Dr. Lawrence Henshaw Memorial Hospital, Calabar, Nigeria. The study was a Cross-sectional retrospective 
study conducted by reviewing patient data from the pharmaceutical monthly summary form from May 2012 to-
June 2013. Majority of the clients, 73(63%) were males while 43(37%) were females, 116 clients were screen for 
ADR and out of this number 84(72%) had an adverse drug reaction of various severity grades. The reported 
incidence of ADR was much higher among male clients 54(74%) than the female clients 30(70%). Interventions 
were provided for clients who reported ADR and the Number of clients documented for Adverse Drug Reactions 
(ADRs) interventions were 84(100%), some clients were provided with more than one ADR interventions. 
Keywords: ADRs, HIV., Intervention , Antiretroviral drugs 
 
1. Introduction 
Patient safety is considered a key element in the overall quality of care of patient accessing antiretroviral therapy. 
The commencement of Highly Active Antiretroviral Therapy (HAART) has resulted in remarkable decreases in 
the rate HIV morbidity and mortality in both the developed and developing countries including Nigeria (Palella, 
et al,2006) and this highly active antiretroviral drugs has been flaunted as one of the greatest advances in the 
response to the HIV pandemic globally. Encumbrance of toxicity resulting from highly active antiretroviral 
therapy (HAART) is of public health concern as it constitutes a threat to sustained success of HIV treatment 
(Dieleman, 2002). Monitoring ADR among patients is important to pharmaceutical care which can be defined as 
responsible provision of medication-related care designed to achieve definite outcome that improves patient 
quality of life (ASHP, 1993).  
Pharmaceutical care is also aimed at eliminating or reducing drug therapy related problems including 
ADR. As interventions, HAART regimen may be changed or replaced with another due to drug resistance and 
HAART may be modified or interrupted as a result of adverse effects or virologic failure (Tayal, Gupta, Nagpal, 
Kumar, 2010).  Studies have shown that  adverse effects may in themselves result in virologic failure or disease 
development as a result of sub optimal dosing or treatment interruption for example in a study by Monforte, 
d'Arminio, Lepri, Rezza ,Pezzotti, Antinori, &Phillips, (2000 ) , 21% of those who discontinued therapy did so 
because of associated toxicity of the drugs . Also In a study carried out in India about ninety percent of all the 
patients on ART developed an adverse drug reaction and  about 618 episodes were recorded in various systems, 
the abdominal and central nervous systems were the most affected (Tayal, et al 2010).  Making available data on 
the types and rates of adverse reactions is important to the success of any HAART program. With limited local 
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data on adverse reactions and an increase in the availability of HAART services, there is need to report pattern of 
adverse drug reactions for timely intervention.  
 
2. Research Methodology 
2.1 Study Setting 
This study was carried out in Dr. Lawrence Henshaw Memorial Hospital (DLHMH),a Hospital owned by the 
Cross River state Government. It was founded in 1905. The health institution was formerly known as Infectious 
Disease Hospital (IDH) because it was mainly taking care of people with tuberculosis, leprosy and other 
infectious disease. It serves people from all the states in South-South and South East. It was renamed DLHMH in 
2005.  In 2007, it was activated to offer comprehensive ART services under the Global HIV/AIDS Initiative in 
Nigeria (GHAIN) program.  The current Strengthening Integrated Delivery of HIV/AIDS Services (SIDHAS) 
program have been supporting the facility immensely after GHAIN. Presently, the facility handles infectious 
diseases e.g. HIV care/treatment, tuberculosis and Multi-Drug Resistant Tuberculosis (MDR-TB). The 
ultramodern MDR-TB ward started operation in 2012. It has fourteen (14) bed space. Also there is an ultra-
modern MDR-TB Laboratory sponsored by Family Health International (FHI360) in the facility. To ensure the 
safety and proper care of clients, the hospital is made-up of a male chest ward, female chest ward, general ward 
and casualty. There are five (5) Medical Practitioners, one (1) Pharmacist, and seven (7) Medical Laboratory 
Scientists working in the facility.  
 
2.2 Study Design 
A Cross-sectional retrospective study was conducted reviewing patient data from the pharmaceutical monthly 
summary form from May 2012-June 2013 
 
2.3 Data Analysis 
Data was analyzed using SPSS version 20and Excel and descriptive statistics was conducted and included 
frequency distribution of relevant variables. Incidence of ADR was calculated and reported. 
 
3.0 Findings/Result 
Majority of the clients, 73(63%) were males while 43(37%) were females, 116 clients were screen for ADR and 
out of this number 84(72%) had an adverse drug reaction, while 34 (23%) had never had an adverse drug 
reaction. The reported incidence of ADR was much higher among male clients 54(74%) than the female clients 
30(70%). The reported ADR included; dry mouth 31(14.4%), malaise 20(9.3%), abdominal pain 16(7.4%), 
Anemia 12(5.5%) (Table 1). Adverse drug reactions studied in the reported data indicated that Nausea / 
Vomiting, was more frequent in males (Table 2). Interventions were provided for clients who reported ADR and 
the Number of clients documented for Adverse Drug Reactions (ADRs) interventions were 84(100%), some 
clients were provided with more than one ADR interventions. Interventions provided includes; Referred to 
prescriber / other HCWs/facility for ADR management (71), Patient counseled on how to manage ADR (84), 
Drug therapy initiated/ changed (58). 
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Table1. Frequency distribution of documented ADR 
ADR Description Frequency/Percent 
Nausea / Vomiting 14(6.5) 
Abdominal pain 16(7.4) 
Fever 4(1.8) 
Gastritis 3(1.3) 
Conjunctivitis 1(0.4) 
Anorexia (loss of appetite) 15(6.9) 
Depression 2(0.9) 
Dizziness 5(2.3) 
Dry mouth 31(14.4) 
Headache 12(5.5) 
Insomnia 9(4.1) 
Nightmares 3(1.3) 
Pain, tingling or numbness in hands or feet 2(0.9) 
Visual disturbances (blurred vision etc) 2(0.9) 
Chest pain / Chest discomfort 3(1.3) 
Tinnitus 6(2.7) 
Oedema 3(1.3) 
Palpitation 13(6.0) 
Pruritus (Itching) 3(1.3) 
Hypoglycemia 2(0.9) 
Dehydration 1(0.4) 
Atropy on injection site 1(0.4) 
Polyuria  (Increased micturition) 4(1.8) 
Arthralgia 4(1.8) 
Myopathy 6(2.7) 
Muscle Pain (Myalgia) 4(1.8) 
Anaemia 12(5.5) 
Fatigue/weakness 5(2.3) 
Malaise 20(9.3) 
Psychosis 4(1.8) 
Neurological complications 5(2.3) 
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Table 2. Distribution of documented ADR by sex 
ADR Description Male Female 
Nausea / Vomiting 14 0 
Abdominal pain 11 5 
Fever 4 0 
Gastritis 3 0 
Conjunctivitis 0 1 
Anorexia (loss of appetite) 11 4 
Depression 2 0 
Dizziness 4 1 
Dry mouth 19 12 
Headache 8 4 
Insomnia 8 1 
Nightmares 2 1 
Pain, tingling or numbness in hands or feet 2 0 
Visual disturbances (blurred vision etc) 2 0 
Chest pain / Chest discomfort 2 1 
Tinnitus 5 1 
Oedema 2 1 
Palpitation 12 1 
Pruritus (Itching) 2 1 
Hypoglycemia 0 2 
Dehydration 0 1 
Atropy on injection site 1 0 
Polyuria  (Increased micturition) 4 0 
Arthralgia 4 0 
Myopathy 3 3 
Muscle Pain (Myalgia) 2 2 
Anaemia 8 4 
Fatigue/weakness 3 2 
Malaise 11 9 
Psychosis 3 1 
Neurological complications 5 0 
 
4. DISCUSSION 
The gamut of adverse drug reaction is wide and varied, and the exact cause may be difficult to identify however 
a wide range of group and individual adverse drug reaction effect have been documented and described. 
Research have shown that the impact of HAART on the natural history of HIV infection is undeniably positive 
in terms of overall improved health and clinical outcomes, but it is quite worrisome that  in spite of this, the 
occurrence of adverse reactions to HAART may negatively impact quality of life and adherence to treatment, 
limiting its efficacy (Teodor, Teodor & Luca,2004). Most adverse effects can be determined by appropriate 
clinical examination for specific symptoms and signs, including fatigue with conjunctiva pallor anemia, 
neuropsychiatric problems, peripherial wasting, rash etc (Subbaraman, Chaguturu, Mayer, Flanigan TP, 
&Kumarasamy, 2007). Dry mouth constituted the highest ADR reported among the ART patients followed by, 
malaise 20(9.3%), abdominal pain 16(7.4%), and Anorexia (loss of appetite). There were no reported cases of 
Skin rashes this contradict previous research findings that skin rash and peripheral neuropathy were common 
ADRs in ART patients (Olowookere, Fatiregun , Akinyemi, Bamgboye, Osagbemi ,2013).  
The study findings showed very low occurrence of fever, conjunctivitis, dehydration, atrophy, 
hypoglycemia, blurred vision, pain, tingling or numbness in hands or feet and depression compared to previous 
study findings by Olowookere et al. (2013) . The reported prevalence of ADR was much higher among male 
than the female clients 30(70%), compared to a previous study finding (Singh, Dulhani, Tiwari, Singh &Sinha, 
2009). The majority of the actions taken to treat ADRs were not indicated. Interventions that were provided 
included referral to prescriber / other HCWs/facility for ADR management, counseling of patient on how to 
manage ADR, change of Drug therapy initiated. The study provided the data on the incidence of suspected 
ADRs in patients on ART in DLHMH, Calabar. It also shows that active surveillance for ADRs in HIV-positive 
patients on ART is feasible in resource-constrained health facilities using pharmaceutical care in HIV 
interventions. However, the study excluded ADRs caused by other drug related problems such as medication 
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errors and therapeutic failures. Inadequate pharmacy personnel and high patient load were the major barriers to 
achieving active surveillance for ADRs, thus some ADRs cases in patients may have been missed. 
 
5.CONCLUSION:  
The study reveals a significant incidence of adverse drug reactions occurring in patients on HAART requiring 
case specific interventions. Pharmaceutical care/Pharmacovigilance is therefore recommended for these patients 
to enhance positive treatment outcomes.  
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